Simvastatin therapy decreases MMP-9 levels in obese women
- 1 August 2013
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 53 (10), 1072-1077
- https://doi.org/10.1002/jcph.146
Abstract
Statins exert cholesterol‐independent beneficial effects on multiple targets including the cardiovascular system, in addition to modulating matrix metalloproteinases (MMPs) expression. The purpose of this study was to assess the effects of simvastatin treatment in obese women without comorbidities. We recruited 33 obese women that received placebo or simvastatin at 20 mg/day for 45 days. Plasma MMP‐9, MMP‐2, TIMP‐1, and TIMP‐2 levels were measured using an enzyme‐linked immunosorbent assay (ELISA). Cardiovascular risk was assessed by the Framingham risk score and Castelli indexes I and II. Treatment with simvastatin significantly reduced MMP‐9 levels and the MMP‐9/TIMP‐1 ratio (P < .05) when compared to the placebo group (P > .05). Conversely, we found no effect on MMP‐2, TIMP‐1, and TIMP‐2 levels or on the MMP‐2/TIMP‐2 ratio (P > .05). The Framingham risk score and Castelli I and II indexes were significantly reduced in the simvastatin‐treatment group (P < .05), while we found no effect on the placebo group. These findings may have clinical importance since simvastatin therapy reduced cardiovascular risk and MMP‐9 levels in obese woman without comorbidities, indicating a potentially new therapeutic approach.Keywords
This publication has 32 references indexed in Scilit:
- Increase in MMP-2 activity in overweight and obese women is associated with menopausal statusClimacteric, 2012
- Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean womenClinical Biochemistry, 2012
- Plaque Rupture is a Determinant of Vascular Events in Carotid Artery Atherosclerotic Disease: Involvement of Matrix Metalloproteinases 2 and 9Journal of Clinical Neurology, 2011
- Plasma Levels of Matrix Metalloproteinase-9 are Independently Associated With Psychosocial Factors in a Middle-Aged Normal PopulationPsychosomatic Medicine, 2009
- The Adipocyte as an Endocrine CellEndocrinology and Metabolism Clinics of North America, 2008
- Metalloproteinase-2 and -9 in Diabetic and Nondiabetic Subjects during Acute Coronary SyndromesEndothelium, 2007
- Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial StiffnessArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemiaInternational Journal of Cardiology, 2004
- Adipocyte Produces Matrix Metalloproteinases 2 and 9Diabetes, 2001
- Increased Matrix Metalloproteinase-9 Activity in Unstable Carotid PlaquesStroke, 2000